Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;1848(11 Pt B):3026-31.
doi: 10.1016/j.bbamem.2015.05.006. Epub 2015 May 19.

Antimicrobial peptide resistance in Neisseria meningitidis

Affiliations
Review

Antimicrobial peptide resistance in Neisseria meningitidis

Yih-Ling Tzeng et al. Biochim Biophys Acta. 2015 Nov.

Abstract

Antimicrobial peptides (AMPs) play an important role as a host defense against microbial pathogens and are key components of the human innate immune response. Neisseria meningitidis frequently colonizes the human nasopharynx as a commensal but also is a worldwide cause of epidemic meningitis and rapidly fatal sepsis. In the human respiratory tract, the only known reservoir of N. meningitidis, meningococci are exposed to human endogenous AMPs. Thus, it is not surprising that meningococci have evolved effective mechanisms to confer intrinsic and high levels of resistance to the action of AMPs. This article reviews the current knowledge about AMP resistance mechanisms employed by N. meningitidis. Two major resistance mechanisms employed by meningococci are the constitutive modification of the lipid A head groups of lipooligosaccharides by phosphoethanolamine and the active efflux pump mediated excretion of AMPs. Other factors influencing AMP resistance, such as the major porin PorB, the pilin biogenesis apparatus, and capsular polysaccharides, have also been identified. Even with an inherently high intrinsic resistance, several AMP resistance determinants can be further induced upon exposure to AMPs. Many well-characterized AMP resistance mechanisms in other Gram-negative bacteria are not found in meningococci. Thus, N. meningitidis utilizes a limited but highly effective set of molecular mechanisms to mediate antimicrobial peptide resistance. This article is part of a Special Issue entitled: Bacterial Resistance to Antimicrobial Peptides.

Keywords: Antimicrobial resistance; Efflux pump; Neisseria meningitidis; Phosphoethanolamine modification of lipid A.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic summary of cellular factors influencing antimicrobial peptide resistance in Neisseria meningitidis. AMPs can initiate the self-promoted uptake through electrostatic interactions with negatively charged lipopolysaccharides of the outer membrane or through the secretin apparatus of type IV pili. The constitutive PEA modification of lipid A head groups reduces electrostatic interactions of AMPs with the cell envelop, while both capsule and bleb act to sequester AMPs from reaching the cell surface. The Mtr efflux pump can expel AMPs from either periplasm or cytoplasm by active efflux, and the major outer membrane porin, PorB, also likely functions as an excretion channel.

Similar articles

Cited by

References

    1. Wilder-Smith A. Meningococcal vaccine in travelers. Current opinion in infectious diseases. 2007;20:454–460. - PubMed
    1. C. Centers for Disease Prevention, Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. Morbidity and mortality weekly report. 2010;59:273. - PubMed
    1. Lorick SA, Fishbein D, Weintraub E, Wortley PM, Lee GM, Zhou F, Davis R. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality. BMC infectious diseases. 2009;9:175. - PMC - PubMed
    1. Clark TA, Stern E, Pondo T, Arnold K, Harrison LH, Vello M. The effect of quadrivalent (A, C, Y,W-135) meningococcal conjugate vaccine on serogroup-specific carriage of Neisseria meningitidis. 16th International pathogenic Neissera conference; Rotterdam, Netherlands. 2008.
    1. Zimmer SM, Stephens DS. Meningococcal conjugate vaccines. Expert Opin. Pharmacother. 2004;5:855–863. - PubMed

Publication types

MeSH terms